Point72 Middle East Fze Edwards Lifesciences Corp Put Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $567,732 - $715,392	9,200 Added 270.59%	12,600 $960,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $76,208 - $102,718	1,100 Added 47.83%	3,400 $235,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $838,523 - $971,599	-10,300 Reduced 81.75%	2,300 $216,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $103,964 - $118,314	-1,400 Reduced 10.0%	12,600 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $956,200 - $1.22 Million	14,000 New	14,000 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.